MedTrace Logo

Tissue Microarray of Hematological Malignancies

NCT04142372 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-04-24

No results posted yet for this study

Summary

The aim of the study is to create new tools for improving management of patients with hematological malignancies by combining extensive clinical data from patients newly diagnosed with hematological malignancies and innovative laboratory analyses made on available tissue samples in regional biobanks from these patients.

Conditions

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • University of Eastern Finland

    collaborator OTHER

  • Fimlab Oy

    collaborator UNKNOWN

  • Helsinki University Central Hospital

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Artturi Mäkinen, MD · Tampere University

  • Olli Lohi, MD, PhD · Tampere University

  • Merja Heinäniemi, PhD · University of Eastern Finland

  • Matti Vänskä, MD, PhD · Tampere University Hospital

  • Tiina Lyly-Yrjänäinen, MD, PhD · Tampere University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-10
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04142372 on ClinicalTrials.gov